Figure 2. 2nd MSA patient on nasal foralumab

Figure 2. 2nd MSA patient on nasal foralumab

Marked reduction in Cerebellar white matter uptake following nasal foralumab

Format

PNG

Source

Tiziana Life Sciences Ltd.

Téléchargements